Archive for November 2017

Recall Preparedness

By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and Drug Administration (FDA) balance these risks all of the time when making marketing authorization decisions. These risks can be evaluable or unanticipated. Evaluable risks from readm more…

Read More

Upcoming Webinar to Highlight Homeopathic Drug Stability

MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug products. Slated for Dec. 4 and Dec. 11, 2017, both from 1:00 – 2:00 p.m. ET, the webinars will be led by Pejman Parhami, senior readm more…

Read More

Annual Certification of Drug Product Listings

By Leonard Krause, FDA Connect November 1, 2017 It is that time of year again. Days are getting shorter and colder, and AAHP members who manufacture homeopathic and over-the-counter (OTC) products need to renew their drug manufacturing establishments with U.S. Food and Drug Administration (FDA). This year, however, add one readm more…

Read More